$TXMD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TherapeuticsMD, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in TherapeuticsMD, Inc.. Get notifications about new insider transactions in TherapeuticsMD, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 22 2016 | COFF | TherapeuticsMD, In ... | CARROLL J MARTIN | Director | Option Exercise | A | 5.68 | 25,000 | 142,000 | 25,000 | |
| Dec 22 2016 | COFF | TherapeuticsMD, In ... | Thompson Tommy G | Director | Option Exercise | A | 5.68 | 25,000 | 142,000 | 25,000 | |
| Dec 22 2016 | COFF | TherapeuticsMD, In ... | SEGAL NICHOLAS | Director | Option Exercise | A | 5.68 | 25,000 | 142,000 | 25,000 | |
| Dec 22 2016 | COFF | TherapeuticsMD, In ... | MUSING JULES A. | Director | Option Exercise | A | 5.68 | 25,000 | 142,000 | 25,000 | |
| Dec 22 2016 | COFF | TherapeuticsMD, In ... | LaPenta Robert V Jr | Director | Option Exercise | A | 5.68 | 25,000 | 142,000 | 25,000 | |
| Dec 22 2016 | COFF | TherapeuticsMD, In ... | Collins Cooper C. | Director | Option Exercise | A | 5.68 | 25,000 | 142,000 | 25,000 | |
| May 06 2016 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | X | 0.41 | 61,372 | 25,003 | 0 | |
| May 06 2016 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Buy | X | 0.41 | 61,372 | 25,003 | 6,557,371 | 6.5 M to 6.6 M (+0.94 %) |
| Mar 14 2016 | COFF | TherapeuticsMD, In ... | Collins Cooper C. | Director | Buy | P | 6.23 | 16,000 | 99,717 | 36,000 | 20 K to 36 K (+80.00 %) |
| Dec 21 2015 | COFF | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | A | 8.92 | 950,000 | 8,474,000 | 950,000 | |
| Dec 21 2015 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | A | 8.92 | 325,000 | 2,899,000 | 325,000 | |
| Dec 21 2015 | COFF | TherapeuticsMD, In ... | Donegan Michael C | Vice President Fina ... | Option Exercise | A | 8.92 | 100,000 | 892,000 | 100,000 | |
| Dec 21 2015 | COFF | TherapeuticsMD, In ... | Thompson Tommy G | Director | Option Exercise | A | 8.92 | 75,000 | 669,000 | 75,000 | |
| Dec 21 2015 | COFF | TherapeuticsMD, In ... | CARROLL J MARTIN | Director | Option Exercise | A | 8.92 | 50,000 | 446,000 | 50,000 | |
| Dec 21 2015 | COFF | TherapeuticsMD, In ... | LaPenta Robert V Jr | Director | Option Exercise | A | 8.92 | 50,000 | 446,000 | 50,000 | |
| Dec 21 2015 | COFF | TherapeuticsMD, In ... | MUSING JULES A. | Director | Option Exercise | A | 8.92 | 50,000 | 446,000 | 50,000 | |
| Dec 21 2015 | COFF | TherapeuticsMD, In ... | Russell Angus C. | Director | Option Exercise | A | 8.92 | 50,000 | 446,000 | 50,000 | |
| Dec 21 2015 | COFF | TherapeuticsMD, In ... | SEGAL NICHOLAS | Director | Option Exercise | A | 8.92 | 50,000 | 446,000 | 50,000 | |
| Dec 21 2015 | COFF | TherapeuticsMD, In ... | Collins Cooper C. | Director | Option Exercise | A | 8.92 | 50,000 | 446,000 | 50,000 | |
| Dec 21 2015 | COFF | TherapeuticsMD, In ... | Cartwright Daniel A | CFO, Treasurer | Option Exercise | A | 8.92 | 325,000 | 2,899,000 | 325,000 | |
| Dec 21 2015 | COFF | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | A | 8.92 | 500,000 | 4,460,000 | 500,000 | |
| Dec 21 2015 | COFF | TherapeuticsMD, In ... | Krassan Mitchell | EVP, Chief Strategy ... | Option Exercise | A | 8.92 | 150,000 | 1,338,000 | 150,000 | |
| Aug 27 2015 | COFF | TherapeuticsMD, In ... | Russell Angus C. | Director | Buy | P | 5.98 | 13,500 | 80,784 | 48,500 | 35 K to 48.5 K (+38.57 %) |
| Aug 24 2015 | COFF | TherapeuticsMD, In ... | Thompson Tommy G | Director | Buy | P | 6.29 | 10,000 | 62,939 | 10,000 | 0 to 10 K |
| Aug 24 2015 | COFF | TherapeuticsMD, In ... | Thompson Tommy G | Director | Buy | P | 6.29 | 343 | 2,159 | 1,000 | 657 to 1,000 (+52.21 %) |
| Aug 24 2015 | COFF | TherapeuticsMD, In ... | Thompson Tommy G | Director | Buy | P | 6.29 | 455 | 2,864 | 1,000 | 545 to 1,000 (+83.49 %) |
| Jun 10 2015 | COFF | TherapeuticsMD, In ... | Krassan Mitchell | EVP, Chief Strategy ... | Option Exercise | M | 0.20 | 30,000 | 6,111 | 683,955 | |
| Jun 10 2015 | COFF | TherapeuticsMD, In ... | Krassan Mitchell | EVP, Chief Strategy ... | Sell | S | 8.18 | 30,000 | 245,400 | 0 | 30 K to 0 (-100.00 %) |
| Jun 10 2015 | COFF | TherapeuticsMD, In ... | Krassan Mitchell | EVP, Chief Strategy ... | Buy | M | 0.20 | 30,000 | 6,111 | 30,000 | 0 to 30 K |
| May 22 2015 | COFF | TherapeuticsMD, In ... | Krassan Mitchell | EVP, Chief Strategy ... | Option Exercise | M | 0.19 | 60,000 | 11,244 | 105,703 | |
| May 22 2015 | COFF | TherapeuticsMD, In ... | Krassan Mitchell | EVP, Chief Strategy ... | Sell | S | 6.56 | 60,000 | 393,354 | 0 | 60 K to 0 (-100.00 %) |
| May 22 2015 | COFF | TherapeuticsMD, In ... | Krassan Mitchell | EVP, Chief Strategy ... | Buy | M | 0.19 | 60,000 | 11,244 | 60,000 | 0 to 60 K |
| May 13 2015 | COFF | TherapeuticsMD, In ... | Russell Angus C. | Director | Buy | P | 6.15 | 35,000 | 215,317 | 35,000 | 0 to 35 K |
| May 12 2015 | COFF | TherapeuticsMD, In ... | CARROLL J MARTIN | Director | Buy | P | 6.11 | 10,000 | 61,100 | 10,000 | 0 to 10 K |
| May 12 2015 | COFF | TherapeuticsMD, In ... | Thompson Tommy G | Director | Buy | P | 6.09 | 3,000 | 18,270 | 3,555 | 555 to 3.6 K (+540.54 %) |
| May 12 2015 | COFF | TherapeuticsMD, In ... | Thompson Tommy G | Director | Buy | P | 6.09 | 3,000 | 18,270 | 661,257 | 658.3 K to 661.3 K (+0.46 %) |
| Mar 27 2015 | COFF | TherapeuticsMD, In ... | Thompson Tommy G | Director | Option Exercise | A | 5.92 | 125,000 | 740,000 | 125,000 | |
| Mar 26 2015 | COFF | TherapeuticsMD, In ... | Russell Angus C. | Director | Option Exercise | A | 5.92 | 100,000 | 592,000 | 100,000 | |
| Mar 26 2015 | COFF | TherapeuticsMD, In ... | CARROLL J MARTIN | Director | Option Exercise | A | 5.92 | 100,000 | 592,000 | 100,000 | |
| Mar 26 2015 | COFF | TherapeuticsMD, In ... | SEGAL NICHOLAS | Director | Option Exercise | A | 5.92 | 100,000 | 592,000 | 100,000 | |
| Mar 26 2015 | COFF | TherapeuticsMD, In ... | MUSING JULES A. | Director | Option Exercise | A | 5.92 | 100,000 | 592,000 | 100,000 | |
| Mar 26 2015 | COFF | TherapeuticsMD, In ... | LaPenta Robert V Jr | Director | Option Exercise | A | 5.92 | 100,000 | 592,000 | 100,000 | |
| Mar 26 2015 | COFF | TherapeuticsMD, In ... | Collins Cooper C. | Director | Option Exercise | A | 5.92 | 100,000 | 592,000 | 100,000 | |
| Nov 24 2014 | COFF | TherapeuticsMD, In ... | Krassan Mitchell | EVP, Chief Strategy ... | Option Exercise | A | 4.01 | 75,000 | 300,750 | 75,000 | |
| Nov 24 2014 | COFF | TherapeuticsMD, In ... | Cartwright Daniel A | CFO, VP Finance, Tr ... | Option Exercise | M | 0.38 | 40,000 | 15,200 | 260,000 | |
| Nov 24 2014 | COFF | TherapeuticsMD, In ... | Cartwright Daniel A | CFO, VP Finance, Tr ... | Sell | S | 3.93 | 20,000 | 78,686 | 0 | 20 K to 0 (-100.00 %) |
| Nov 24 2014 | COFF | TherapeuticsMD, In ... | Cartwright Daniel A | CFO, VP Finance, Tr ... | Sell | S | 3.88 | 20,000 | 77,598 | 20,000 | 40 K to 20 K (-50.00 %) |
| Nov 24 2014 | COFF | TherapeuticsMD, In ... | Cartwright Daniel A | CFO, VP Finance, Tr ... | Buy | M | 0.38 | 40,000 | 15,200 | 40,000 | 0 to 40 K |
| Sep 11 2014 | COFF | TherapeuticsMD, In ... | Thompson Tommy G | Director | Option Exercise | M | 2.80 | 2,500 | 7,000 | 62,500 | |
| Sep 11 2014 | COFF | TherapeuticsMD, In ... | Thompson Tommy G | Director | Buy | M | 2.80 | 2,500 | 7,000 | 658,257 | 655.8 K to 658.3 K (+0.38 %) |
| Sep 08 2014 | COFF | TherapeuticsMD, In ... | Thompson Tommy G | Director | Buy | P | 5.48 | 657 | 3,600 | 655,757 | 655.1 K to 655.8 K (+0.10 %) |
| Sep 08 2014 | COFF | TherapeuticsMD, In ... | Thompson Tommy G | Director | Buy | P | 5.42 | 545 | 2,954 | 655,100 | 654.6 K to 655.1 K (+0.08 %) |
| Sep 08 2014 | COFF | TherapeuticsMD, In ... | Thompson Tommy G | Director | Buy | P | 5.40 | 226 | 1,220 | 654,555 | 654.3 K to 654.6 K (+0.03 %) |
| Sep 08 2014 | COFF | TherapeuticsMD, In ... | Thompson Tommy G | Director | Buy | P | 5.40 | 329 | 1,777 | 654,329 | 654 K to 654.3 K (+0.05 %) |
| Jun 25 2014 | COFF | TherapeuticsMD, In ... | MUSING JULES A. | Director | Option Exercise | A | 5.18 | 250,000 | 1,295,000 | 250,000 | |
| Jun 11 2014 | COFF | TherapeuticsMD, In ... | Thompson Tommy G | Director | Option Exercise | M | 2.80 | 10,000 | 28,000 | 65,000 | |
| Jun 11 2014 | COFF | TherapeuticsMD, In ... | Thompson Tommy G | Director | Buy | M | 2.80 | 10,000 | 28,000 | 654,000 | 644 K to 654 K (+1.55 %) |
| Jun 09 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | M | 0.10 | 10,000 | 1,018 | 1,462,910 | |
| Jun 09 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Buy | M | 0.10 | 10,000 | 1,018 | 6,745,999 | 6.7 M to 6.7 M (+0.15 %) |
| Jun 09 2014 | COFF | TherapeuticsMD, In ... | Collins Cooper C. | Director | Buy | P | 3.84 | 20,000 | 76,890 | 20,000 | 0 to 20 K |
| May 14 2014 | COFF | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 20,000 | 2,036 | 2,032,255 | |
| May 14 2014 | COFF | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 20,000 | 2,036 | 1,742,419 | 1.7 M to 1.7 M (+1.16 %) |
| May 13 2014 | COFF | TherapeuticsMD, In ... | LaPenta Robert V Jr | Director | Buy | P | 3.72 | 3,000 | 11,160 | 10,000 | 7 K to 10 K (+42.86 %) |
| May 13 2014 | COFF | TherapeuticsMD, In ... | LaPenta Robert V Jr | Director | Buy | P | 3.58 | 2,000 | 7,160 | 7,000 | 5 K to 7 K (+40.00 %) |
| May 12 2014 | COFF | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 3.00 | 31,526 | 94,578 | 268,474 | |
| May 12 2014 | COFF | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 3.00 | 31,526 | 94,578 | 21,061,059 | 21 M to 21.1 M (+0.15 %) |
| May 09 2014 | COFF | TherapeuticsMD, In ... | Thompson Tommy G | Director | Buy | P | 3.57 | 14,000 | 50,039 | 644,000 | 630 K to 644 K (+2.22 %) |
| Mar 28 2014 | COFF | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 6.70 | 982,053 | 6,576,907 | 21,029,533 | 22 M to 21 M (-4.46 %) |
| Mar 28 2014 | COFF | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 6.70 | 353,412 | 2,366,836 | 3,892,187 | 4.2 M to 3.9 M (-8.32 %) |
| Mar 28 2014 | COFF | TherapeuticsMD, In ... | SEGAL NICHOLAS | Director | Sell | S | 6.70 | 185,298 | 1,240,959 | 225,809 | 411.1 K to 225.8 K (-45.07 %) |
| Mar 28 2014 | COFF | TherapeuticsMD, In ... | SEGAL NICHOLAS | Director | Sell | S | 6.70 | 30,000 | 200,913 | 215,485 | 245.5 K to 215.5 K (-12.22 %) |
| Mar 27 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Sell | S | 6.70 | 421,268 | 2,821,274 | 6,735,999 | 7.2 M to 6.7 M (-5.89 %) |
| Mar 10 2014 | COFF | TherapeuticsMD, In ... | Krassan Mitchell | EVP, Chief Strategy ... | Option Exercise | M | 0.19 | 7,500 | 1,406 | 143,203 | |
| Mar 10 2014 | COFF | TherapeuticsMD, In ... | Krassan Mitchell | EVP, Chief Strategy ... | Sell | S | 7.73 | 7,500 | 57,990 | 0 | 7.5 K to 0 (-100.00 %) |
| Mar 10 2014 | COFF | TherapeuticsMD, In ... | Krassan Mitchell | EVP, Chief Strategy ... | Buy | M | 0.19 | 7,500 | 1,406 | 7,500 | 0 to 7.5 K |
| Mar 10 2014 | COFF | TherapeuticsMD, In ... | Milligan John C.K. IV | President and Secre ... | Gift | G | 0.00 | 300,000 | 0 | 1,722,419 | 2 M to 1.7 M (-14.83 %) |
| Mar 10 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | S | 5.05 | 11,138 | 56,247 | 45,000 | |
| Mar 10 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | S | 2.64 | 12,375 | 32,670 | 50,000 | |
| Mar 10 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | S | 2.55 | 37,125 | 94,669 | 150,000 | |
| Mar 10 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | S | 2.55 | 12,375 | 31,556 | 50,000 | |
| Mar 10 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | S | 0.41 | 15,190 | 6,188 | 61,372 | |
| Mar 10 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | S | 0.10 | 364,545 | 37,111 | 1,472,910 | |
| Mar 10 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | J | 5.05 | 11,583 | 58,494 | 45,000 | |
| Mar 10 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | J | 2.64 | 12,870 | 33,977 | 50,000 | |
| Mar 10 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | J | 2.55 | 38,610 | 98,456 | 150,000 | |
| Mar 10 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | J | 2.55 | 12,870 | 32,819 | 50,000 | |
| Mar 10 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | J | 0.41 | 15,797 | 6,436 | 61,372 | |
| Mar 10 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | J | 0.10 | 379,127 | 38,595 | 1,472,910 | |
| Mar 10 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | S | 5.05 | 112 | 566 | 45,000 | |
| Mar 10 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | S | 2.64 | 125 | 330 | 50,000 | |
| Mar 10 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | S | 2.55 | 375 | 956 | 150,000 | |
| Mar 10 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | S | 2.55 | 125 | 319 | 50,000 | |
| Mar 10 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | S | 0.41 | 153 | 62 | 61,372 | |
| Mar 10 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | S | 0.10 | 3,682 | 375 | 1,472,910 | |
| Mar 10 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Sell | S | 0.00 | 1,771,424 | 0 | 7,157,267 | 8.9 M to 7.2 M (-19.84 %) |
| Mar 10 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Sell | J | 0.00 | 1,842,281 | 0 | 7,157,267 | 9 M to 7.2 M (-20.47 %) |
| Mar 10 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Sell | S | 0.00 | 17,893 | 0 | 7,157,267 | 7.2 M to 7.2 M (-0.25 %) |
| Feb 26 2014 | COFF | TherapeuticsMD, In ... | Milligan John C.K. IV | President | Sell | S | 6.53 | 8,400 | 54,839 | 6,318,018 | 6.3 M to 6.3 M (-0.13 %) |
| Feb 26 2014 | COFF | TherapeuticsMD, In ... | Milligan John C.K. IV | President | Sell | S | 6.16 | 8,300 | 51,117 | 6,326,418 | 6.3 M to 6.3 M (-0.13 %) |
| Feb 26 2014 | COFF | TherapeuticsMD, In ... | Milligan John C.K. IV | President | Sell | S | 6.23 | 8,300 | 51,735 | 6,334,718 | 6.3 M to 6.3 M (-0.13 %) |
| Feb 21 2014 | COFF | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 6.18 | 16,600 | 102,590 | 22,011,586 | 22 M to 22 M (-0.08 %) |
| Feb 21 2014 | COFF | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 6.17 | 16,700 | 103,089 | 22,028,186 | 22 M to 22 M (-0.08 %) |
| Feb 21 2014 | COFF | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 6.17 | 16,700 | 103,007 | 22,044,886 | 22.1 M to 22 M (-0.08 %) |
| Feb 13 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Sell | S | 6.05 | 15,625 | 94,586 | 7,457,267 | 7.5 M to 7.5 M (-0.21 %) |
| Feb 13 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Sell | S | 6.27 | 15,625 | 97,928 | 7,472,892 | 7.5 M to 7.5 M (-0.21 %) |
| Feb 12 2014 | COFF | TherapeuticsMD, In ... | Krassan Mitchell | EVP, Chief Strategy ... | Option Exercise | M | 0.19 | 7,500 | 1,406 | 150,703 | |
| Feb 12 2014 | COFF | TherapeuticsMD, In ... | Krassan Mitchell | EVP, Chief Strategy ... | Sell | S | 6.34 | 7,500 | 47,518 | 0 | 7.5 K to 0 (-100.00 %) |
| Feb 12 2014 | COFF | TherapeuticsMD, In ... | Krassan Mitchell | EVP, Chief Strategy ... | Buy | M | 0.19 | 7,500 | 1,406 | 7,500 | 0 to 7.5 K |
| Jan 30 2014 | COFF | TherapeuticsMD, In ... | Milligan John C.K. IV | President, Secretar ... | Sell | S | 6.49 | 8,400 | 54,553 | 6,343,018 | 6.4 M to 6.3 M (-0.13 %) |
| Jan 30 2014 | COFF | TherapeuticsMD, In ... | Milligan John C.K. IV | President, Secretar ... | Sell | S | 6.03 | 8,300 | 50,050 | 6,351,418 | 6.4 M to 6.4 M (-0.13 %) |
| Jan 30 2014 | COFF | TherapeuticsMD, In ... | Milligan John C.K. IV | President, Secretar ... | Sell | S | 5.94 | 8,300 | 49,315 | 6,359,718 | 6.4 M to 6.4 M (-0.13 %) |
| Jan 23 2014 | COFF | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 5.92 | 16,600 | 98,343 | 22,061,586 | 22.1 M to 22.1 M (-0.08 %) |
| Jan 23 2014 | COFF | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 5.66 | 16,700 | 94,565 | 22,078,186 | 22.1 M to 22.1 M (-0.08 %) |
| Jan 23 2014 | COFF | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 5.53 | 16,700 | 92,321 | 22,094,886 | 22.1 M to 22.1 M (-0.08 %) |
| Jan 15 2014 | COFF | TherapeuticsMD, In ... | Krassan Mitchell | EVP, Chief Strategy ... | Option Exercise | M | 0.19 | 7,500 | 1,406 | 158,203 | |
| Jan 15 2014 | COFF | TherapeuticsMD, In ... | Krassan Mitchell | EVP, Chief Strategy ... | Sell | S | 5.73 | 7,500 | 42,947 | 0 | 7.5 K to 0 (-100.00 %) |
| Jan 15 2014 | COFF | TherapeuticsMD, In ... | Krassan Mitchell | EVP, Chief Strategy ... | Buy | M | 0.19 | 7,500 | 1,406 | 7,500 | 0 to 7.5 K |
| Jan 08 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | A | 5.05 | 45,000 | 227,250 | 1,829,282 | |
| Jan 08 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Sell | S | 5.21 | 15,625 | 81,431 | 7,488,517 | 7.5 M to 7.5 M (-0.21 %) |
| Jan 08 2014 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Sell | S | 5.04 | 15,625 | 78,823 | 7,504,142 | 7.5 M to 7.5 M (-0.21 %) |
| Jan 08 2014 | COFF | TherapeuticsMD, In ... | SEGAL NICHOLAS | Director | Option Exercise | A | 5.05 | 45,000 | 227,250 | 298,429 | |
| Jan 08 2014 | COFF | TherapeuticsMD, In ... | MUSING JULES A. | Director | Option Exercise | A | 5.05 | 45,000 | 227,250 | 45,000 | |
| Jan 08 2014 | COFF | TherapeuticsMD, In ... | Thompson Tommy G | Director | Option Exercise | A | 5.05 | 70,000 | 353,500 | 620,000 | |
| Jan 08 2014 | COFF | TherapeuticsMD, In ... | LaPenta Robert V Jr | Director | Option Exercise | A | 5.05 | 70,000 | 353,500 | 220,000 | |
| Jan 08 2014 | COFF | TherapeuticsMD, In ... | Collins Cooper C. | Director | Option Exercise | X | 5.05 | 70,000 | 353,500 | 220,000 | |
| Jan 08 2014 | COFF | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | A | 5.05 | 45,000 | 227,250 | 0 | |
| Dec 17 2013 | COFF | TherapeuticsMD, In ... | Thompson Tommy G | Director | Option Exercise | A | 4.43 | 250,000 | 1,107,500 | 550,000 | |
| Dec 17 2013 | COFF | TherapeuticsMD, In ... | Thompson Tommy G | Director | Buy | P | 1.70 | 30,000 | 51,000 | 630,000 | 600 K to 630 K (+5.00 %) |
| Aug 28 2013 | COFF | TherapeuticsMD, In ... | Bernick Brian | Chief Medical Offic ... | Sell | S | 1.55 | 1,600,000 | 2,480,000 | 7,519,767 | 9.1 M to 7.5 M (-17.54 %) |
| Aug 28 2013 | COFF | TherapeuticsMD, In ... | MUSING JULES A. | Director | Buy | P | 2.15 | 6,318 | 13,584 | 22,400 | 16.1 K to 22.4 K (+39.29 %) |
| Aug 27 2013 | COFF | TherapeuticsMD, In ... | MUSING JULES A. | Director | Buy | P | 2.15 | 952 | 2,047 | 16,082 | 15.1 K to 16.1 K (+6.29 %) |
| Aug 27 2013 | COFF | TherapeuticsMD, In ... | MUSING JULES A. | Director | Buy | P | 2.15 | 4,330 | 9,310 | 15,130 | 10.8 K to 15.1 K (+40.09 %) |
| Aug 28 2013 | COFF | TherapeuticsMD, In ... | SEGAL NICHOLAS | Director | Buy | P | 1.55 | 74,128 | 114,898 | 730,723 | 656.6 K to 730.7 K (+11.29 %) |
| Aug 23 2013 | COFF | TherapeuticsMD, In ... | MUSING JULES A. | Director | Option Exercise | A | 2.16 | 50,000 | 108,000 | 50,000 | |
| Jun 17 2013 | COFF | TherapeuticsMD, In ... | Collins Cooper C. | Director | Sell | S | 1.75 | 2,631,579 | 4,605,263 | 0 | 2.6 M to 0 (-100.00 %) |
| May 03 2013 | COFF | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | A | 2.64 | 50,000 | 132,000 | 3,517,627 | |
| May 03 2013 | COFF | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | A | 2.64 | 50,000 | 132,000 | 1,784,282 | |
| May 03 2013 | COFF | TherapeuticsMD, In ... | Greco Samuel A | Director | Option Exercise | A | 2.64 | 50,000 | 132,000 | 100,000 | |
| May 03 2013 | COFF | TherapeuticsMD, In ... | SEGAL NICHOLAS | Director | Option Exercise | A | 2.64 | 50,000 | 132,000 | 253,429 | |
| May 03 2013 | COFF | TherapeuticsMD, In ... | Thompson Tommy G | Chairman | Option Exercise | A | 2.64 | 150,000 | 396,000 | 300,000 | |
| May 03 2013 | COFF | TherapeuticsMD, In ... | Thompson Tommy G | Chairman | Option Exercise | A | 2.64 | 75,000 | 198,000 | 150,000 | |
| May 03 2013 | COFF | TherapeuticsMD, In ... | Collins Cooper C. | Director | Option Exercise | A | 2.64 | 75,000 | 198,000 | 150,000 | |
| May 03 2013 | COFF | TherapeuticsMD, In ... | LaPenta Robert V Jr | Director | Option Exercise | A | 2.64 | 75,000 | 198,000 | 150,000 | |
| Dec 04 2012 | COFF | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | A | 3.00 | 800,000 | 2,400,000 | 3,493,198 | |
| Dec 04 2012 | COFF | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | A | 2.55 | 75,000 | 191,250 | 2,693,198 | |
| Dec 04 2012 | COFF | TherapeuticsMD, In ... | Finizio Robert G | CEO, Director | Option Exercise | A | 3.00 | 900,000 | 2,700,000 | 2,927,481 | |
| Dec 04 2012 | COFF | TherapeuticsMD, In ... | Finizio Robert G | CEO, Director | Option Exercise | A | 2.55 | 50,000 | 127,500 | 2,027,481 | |
| Dec 04 2012 | COFF | TherapeuticsMD, In ... | Cartwright Daniel A | CFO, VP Finance, Tr ... | Option Exercise | A | 3.00 | 700,000 | 2,100,000 | 1,600,000 | |
| Dec 04 2012 | COFF | TherapeuticsMD, In ... | Cartwright Daniel A | CFO, VP Finance, Tr ... | Option Exercise | A | 0.38 | 600,000 | 228,000 | 900,000 | |
| Dec 04 2012 | COFF | TherapeuticsMD, In ... | Cartwright Daniel A | CFO, VP Finance, Tr ... | Option Exercise | A | 0.38 | 300,000 | 114,000 | 300,000 |